CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
Bharat Forge Ltd. 25/07/20241,593.85952.3007/04/2025 -40.25% 256 days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

API business opportunities push Aarti Drugs; stock zooms 132 per cent in 6 months

Nidhi Jani 0 4262 Article rating: 4.2

Currently, India imports over 60 per cent of its APIs consumption from China and other countries, which opens up significant opportunities for Indian API manufacturers like Aarti Drugs. The company has geared up its API production by nearly 44 per cent to 25,591 MT in FY20.

Granules recall twelve lots of Metformin Hydrochloride ER tablets

DSIJ Intelligence 0 1866 Article rating: 4.9

Granules Pharmaceuticals, Inc., (Chantilly, Virginia), which is a wholly-owned subsidiary of Granules India Limited, has voluntarily recalled 12 lots of Metformin Hydrochloride extended-release tablets USP, 750 mg, 100 and 500 count bottles within expiry to the consumer level due to the detection of N-Nitrosodimethylamine (NDMA) levels above the acceptable daily intake (ADI).

Balaji Amines jumps seven per cent owing to developing expansion plans

Pratik Shastri 0 1802 Article rating: 4.0

Moreover, prospective growth triggers are likely for its agrochemical business. Various factors are at play for this such as the storage levels in water reservoirs across the country, a hike in minimum support price (MSP) of key Kharif crops and an anticipated strong monsoon spread.

COVID-19 vaccine of Zydus Cadila gets nod to initiate human clinical trials

DSIJ Intelligence 0 2029 Article rating: 4.9

The vaccine candidate ZyCov-D has been developed originally at the company’s research centre-Vaccine Technology Centre (VTC) in Ahmedabad, India. The vaccine when tested on animals brings out a strong immune response in multiple animal species like mice, rats, guinea pigs and rabbits. 

Index trend and stocks in action on July 03, 2020

DSIJ Intelligence-3 0 1225 Article rating: 5.0

The level of 10,600 would act as immediate resistance and on the downside, the level of 10,480 followed by 10,400, are likely to act as an important support zone. Stocks in news: PTC India Financial Services, Reliance Industries, Cadila Healthcare, JB Chemicals & Pharmaceuticals, Motherson Sumi, Hindustan Unilever.

All is well that ends well!

DSIJ Intelligence-3 0 734 Article rating: 4.8

In the previous trading session, Nifty and Sensex ascended to the highest level in four months, where Nifty contentedly settled above its psychological level of 10,500. Auto stocks contributed largely to the rally as the monthly figures showed some optimistic trend, especially in two-wheelers and tractors segment.

Sensex gains by more than 400 points; Mahindra & Mahindra rallies by 6 per cent

DSIJ Intelligence 0 633 Article rating: 5.0

Following gains in auto and IT stocks, domestic benchmark indices ended today's trading session on a positive note with Sensex gaining by 429.25 points or 1.21 per cent to close at 35,843.70 levels while Nifty increased by 121.65 points or 1.17 per cent to settle at 10,551.70.

Kerbside

Ninad Ramdasi 0 1123 Article rating: No rating

The recommendations provided in this column are taken from various market sources such as brokers, analysts, dealers and investment strategists, etc. These recommendations may not be backed by strong fundamentals. Therefore we advise readers to use their own discretion before investing in these recommendation

Reviews

Ninad Ramdasi 0 1120 Article rating: No rating

In this edition, we have reviewed Parag Milk Foods Limited and Bajaj Finance Limited. We suggest our reader-investors to HOLD in Parag Milk Foods Limited and Bajaj Finance Limited.

Query Board

Ninad Ramdasi 0 2591 Article rating: 5.0

This section gives decisive investment rationales to our subscribers on the stock queries they have raised to our research team.

Airline & Tourism Industry : Flying With Clipped Wings

Ninad Ramdasi 0 897 Article rating: No rating

The pandemic has dealt out a severe blow to the airline and tourism industry and it is unlikely to emerge from this situation soon enough. Geyatee Deshpande discusses that while gradual phasing out of lockdowns across the world will rejuvenate the air travel sector, the luxury holiday and resort sectors are unlikely to find many takers.

NBFCs : Caught Between A Rock And A Hard Place

Ninad Ramdasi 0 1160 Article rating: No rating

Non-banking financial companies (NBFCs) have been going through extremely difficult times, first on account of the IL&FS fallout that shook the industry and now due to the virus-triggered pandemic. Anthony Fernandes investigates the overall impact on this sector and studies how the government’s stimulus packages may offer a ray of hope

Opportunity In The Making! ‘Atmanirbhar Bharat

Ninad Ramdasi 0 2455 Article rating: No rating

With heightened nationalism being the current global trend in which every nation is attempting to safeguard its national interest the Atmanirbhar Bharat initiative by the Indian government sounds like a perfect solution, at least superficially, to become self-reliant in an extremely uncertain global economic environment. But what does it mean to equity investors who are bullish on the India story? Yogesh Supekar and Karan Bhojwani draw attention to the sectors which stand to benefit from this initiative while also focusing on sectors that will gain from the increasing angst against Chinese products.

MF Query Board

Ninad Ramdasi 0 669 Article rating: No rating

Readers are requested to send only one query at a time so that more readers get a chance. Have questions relating to any aspect of personal finance. Ask DSIJ at editorial@DSIJ.in and get your queries resolved.

Fund of Fortnight

Ninad Ramdasi 0 881 Article rating: No rating

This is our mutual fund recommendation. Every fortnight , we recommend one open-ended equity diversified fund that has the best potential of returns for the next one year considering its constituents remain the same.

Can Investing In Mutual Funds Make You A BILLIONAIRE?

Ninad Ramdasi 0 1939 Article rating: 3.2

When we read about the lifestyles of the billionaires across the world, doesn’t it ignite a dream to become a part of that exclusive group of people? It does, surely! It also makes us wonder about the strategy or approach that one needs to adopt to become wealthy. Is investing in mutual funds one of those options? Read on to find out

The ‘Golden Touch

Ninad Ramdasi 0 1007 Article rating: No rating

When it comes to asset allocation, equity, debt and real estate form the staple asset classes. As for gold as an asset class, it always creates some sort of confusion in the minds of investors who remain unsure whether to have exposure to it or not.

Quarterly Review

Ninad Ramdasi 0 937 Article rating: No rating

I found your cover story 'The Art of Portfolio Management' very insightful. It has really helped me to understand how to go about reviewing my investment portfolio. However, I would like to know about things that should I look at in a quarterly review.

Sensex jumps by nearly 500 points; Axis Bank gains by more than 6 per cent; Bajaj Finance remains the volume topper

DSIJ Intelligence 0 1130 Article rating: 5.0

Domestic benchmark indices closed higher with Sensex gaining by 498.65 points or 1.43 per cent at 35,414.45 while Nifty jumped by 116.20 points or 1.13 per cent to close at 10,418.30 level.  

RSS
First342343344345347349350351Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR